ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000270265.1	Gefitinib	Bladder urothelial carcinoma	0.00904375	Sensitive
ENSG00000270265.1	Gefitinib	Lung squamous cell carcinoma	0.006596103	Sensitive